Article
10 Dec 2024
Biocon Announces FDA Approval Of Ustekinumab Biosimilar
AUTHORS CONTENT
Article
05 Nov 2024
Alvotech And Teva Announce FDA Approval Of Additional Presentation For Ustekinumab Biosimilar
Article
14 Oct 2024
Aflibercept Biosimilar Updates In Europe
Article
01 Oct 2024
Recent Biosimilar Approvals By The FDA
Article
29 Aug 2024
EMA Accepts Marketing Authorization Application For Alvotech's AVT06 (Aflibercept)
Article
23 Jul 2024
FTC Issues Interim Report On Ongoing Study Of Pharmacy Benefit Managers
Article
15 Apr 2024
Janssen v. Teva: Not An April Fool's Day Joke For Life Sciences Companies
Article
11 Mar 2024
Artiva Biotherapeutics Receives FDA Fast Track Designation For AlloNK In Lupus Nephritis
Article
15 Feb 2024
Sandoz To Acquire CIMERLI From Coherus For $170 Million
Article
06 Feb 2024
USPTO Publishes Enablement Guidelines In View Of Amgen v. Sanofi
Article
05 Feb 2024
Federal Circuit Remands To USPTO To Clarify Analysis Of Jepson-Format And Means-Plus-Function Claims In The Field Of Biotechnology
Article
11 Jan 2024
District Court Grants Summary Judgment And Invalidates Patent In REGENXBIO v. Sarepta Litigation
Article
05 Jan 2024
CRISPR Regulatory Updates
Article
05 Jan 2024
Biosimilar Deals Updates: Biocon, AstraZeneca
Article
23 Nov 2023
European Biologics Regulatory Updates
Article
12 Oct 2023
Recent Adalimumab Biosimilar Developments
Article
03 Aug 2023
Bristol-Myers Squibb And AstraZeneca Settle Anti-PD-L1 Antibody Product Litigation
Article
25 May 2023
FDA Approves The Cyltezo Pen, An Autoinjector Option For Adalimumab
Article
27 Apr 2023
FDA Guidance On Continuous Manufacturing Of Drug Substances And Drug Products
Article
22 Mar 2023
Coherus Biosciences Announces Approval Of A Pegfilgrastim Autoinjector
